MétaCan
Menu
Back to cohort

A combinatorial chemical epigenetics screen identifies an off‐target modulation of drug transporter function

2022· article· en· W4225393363 on OpenAlexaff
Samir H. Barghout, Yifan Yu, C.H. Arrowsmith, Dalia Baršytė-Lovejoy

Bibliographic record

VenueThe FASEB Journal · 2022
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicHistone Deacetylase Inhibitors Research
Canadian institutionsStructural Genomics ConsortiumUniversity of Toronto
Fundersnot available
KeywordsEpigeneticsCytotoxicityChemistryBiologyPharmacologyMolecular biologyBiochemistryCancer researchCell biologyIn vitro

Abstract

fetched live from OpenAlex

Anticancer drug response is determined by genetic and epigenetic mechanisms. To identify the epigenetic regulators of anticancer drug response, we conducted a chemical epigenetics screen using chemical probes that target different epigenetic modulators. In this screen, we tested 31 epigenetic probes in combination with 14 mechanistically diverse anticancer agents and measured the viability in A549 lung adenocarcinoma cells by the Resazurin assay. We identified 6 epigenetic probes that significantly potentiated the cytotoxicity of TAK‐243, a first‐in‐class ubiquitin‐activating enzyme (UBA1) inhibitor evaluated in several solid and hematologic malignancies. These probes include TP‐472, GSK‐864, A‐196, UNC1999, SGC‐CBP30 and PFI‐4, and target BRD9/7, mutant IDH1, SUV420H1/H2, EZH2/H1, p300/CBP and BRPF1B, respectively. To validate the screen results, we assessed the viability after combination of TAK‐243 and the identified probes and observed 4‐ to 30‐fold potentiation of TAK‐243 cytotoxicity in myeloma cells. Moreover, we tested the identified probes in 13 additional cell lines and observed profound potentiation. Upon combination with a panel of anticancer agents, epigenetic probes did not potentiate their cytotoxicity suggesting the observed effects are selective for TAK‐243. In contrast to epigenetic probes, negative chemical controls did not have a significant impact on TAK‐243 cytotoxicity. As assessed by immunoblotting, potentiation of TAK‐243 cytotoxicity was associated with reduced ubiquitylation and induction of apoptosis. Using the cellular thermal shift assay (CETSA), UBA1 displayed increased engagement with TAK‐243, suggesting the epigenetic probes enhanced intracellular drug accumulation. Mechanistically, the epigenetic probes exerted their potentiation by inhibiting the efflux transporter ABCG2 without inducing significant changes in ubiquitylation pathways or ABCG2 expression levels. Additionally, the identified probes shared significant chemical scaffold similarities with TAK‐243. Based on the screen results, we developed a cell‐based assay that exploits TAK‐243 and ABCG2‐overexpressing cells to reliably quantify the ABCG2‐inhibitory activity of novel compounds. In conclusion, our study identifies epigenetic probes that profoundly potentiate TAK‐243 cytotoxicity through off‐target ABCG2 inhibition. We also provide experimental evidence of the inability of negative controls to exclude a subset of off‐target effects of chemical probes. Finally, we have developed a robust cell‐based assay that can quantitatively evaluate ABCG2 inhibition by drug candidates.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.250
Teacher spread0.239 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueThe FASEB JournalSame topicHistone Deacetylase Inhibitors ResearchFrench-language works237,207